Literature DB >> 16309377

The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population.

Seija Eskelinen1, Pauli Suominen, Tero Vahlberg, Minna Löppönen, Raimo Isoaho, Sirkka-Liisa Kivelä, Kerttu Irjala.   

Abstract

Our aims were: 1) to analyze the effect of the methodology used to derive clinically feasible cut-off values for thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb), which exhibit highly skewed distributions; and 2) to describe the influence of thyroid antibodies on thyroid stimulating hormone (TSH) and free thyroxine (FT4) reference intervals among thyroid disease-free aged subjects. The reference population consisted of 1086 individuals with a mean age of 73 years. The impacts of TPOAb and/or TgAb positivity on the reference intervals of TSH and FT4 were evaluated by both including and excluding subjects with elevated thyroid antibodies. The exclusion of subjects with elevated thyroid antibodies had no effect on the FT4 reference interval in either gender or on the TSH reference interval in men. Among women, the exclusion of 196 (34%) thyroid antibody-positive subjects resulted in lowering of the upper reference limit of TSH from 7.2 to 5.8 mIU/L. When the more stringent "mode-method" by summing mode+(mode-2.5th percentile) was used, 334 women (58%) were excluded and the upper reference limit of TSH remained essentially identical. Regardless of the statistical methodology used to derive cut-off values, the effect of antibody positivity was found to be less than expected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309377     DOI: 10.1515/CCLM.2005.236

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Thyroid hormone levels as a predictor of mortality in intensive care patients: A comparative prospective study.

Authors:  Adnan Tas; Tamer Tetiker; Yavuz Beyazit; Hacer Celik; Yusuf Yesil
Journal:  Wien Klin Wochenschr       Date:  2012-02-15       Impact factor: 1.704

2.  An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits.

Authors:  Laura Boucai; Joseph G Hollowell; Martin I Surks
Journal:  Thyroid       Date:  2010-11-08       Impact factor: 6.568

3.  An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan.

Authors:  Tuanyu Fang; Leweihua Lin; Qianying Ou; Lu Lin; Huachuan Zhang; Kaining Chen; Huibiao Quan; Yangli He
Journal:  Int J Endocrinol       Date:  2022-07-09       Impact factor: 2.803

4.  Effect of thyroid peroxidase antibodies on thyroid-stimulating hormone reference limits in a primarily Latina population.

Authors:  Richard H Lee; Carole A Spencer; Martin N Montoro; Paola Aghajanian; T Murphy Goodwin; Erin A Miller; Ivana Petrovic; Lewis E Braverman; Jorge H Mestman
Journal:  Obstet Med       Date:  2009-11-30

5.  Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study.

Authors:  A Amouzegar; H Delshad; L Mehran; M Tohidi; F Khafaji; F Azizi
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

6.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

Review 7.  Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction.

Authors:  Salman Razvi; Sindeep Bhana; Sanaa Mrabeti
Journal:  J Thyroid Res       Date:  2019-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.